Clinical trial
Prostate Cancer Screening With PSA, Risk Calculator and Multiparametric MRI: a Pilot Study
NCT06238661 is registered in ClinicalTrials.gov with Fondazione del Piemonte per l'Oncologia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prostate Cancer Screening With PSA, Risk Calculator and Multiparametric MRI: a Pilot Study
- Lead sponsor
- Fondazione del Piemonte per l'Oncologia
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- February 17, 2025
- Completion date
- June 30, 2026
- Enrollment
- 4,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer